Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0031350 (pharyngitis)
 2,405 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

During a 16-month period patients who presented to the Syracuse University Health Center with upper respiratory complaints had throat swabs obtained for viral, streptococcal and Mycoplasma pneumoniae cultures. Thirty-five of 613 patients (5.7%) had herpes simplex virus (HSV) isolated. All but 2 of the HSV isolates were found to be type 1 by immunofluorescent staining. Two HSV-positive patients also grew Group A Streptococcus, one grew M. pneumoniae and three had serum heterophile antibody tests that were positive. On physical examination 25 of the 35 HSV-positive patients had pharyngeal erythema and 14 had pharyngeal exudate. Twelve of these patients had vesicular lesions of the lips, throat or gums associated with their other symptoms. For 29 of the 35 HSV-positive students the primary diagnosis assigned was pharyngitis, for 2 the diagnosis was stomatitis and the remainder were assigned a primary diagnosis of upper respiratory infection, pneumonia, bronchitis or dental infection. Thirty-two of the 35 HSV-positive patients were treated with oral antibiotics and 7 were treated with oral or topical acyclovir. During the same 16-month period 89 (6.9%) of 1297 students presenting with sore throat were culture-positive for influenza A or B, 30 (2.3%) of 1283 were culture-positive for M. pneumoniae and 169 (2.8%) of the 6016 cultured for Group A Streptococcus were positive. Serum was tested for heterophile antibody in 2438 students, and 257 (10.5%) were positive. Herpes simplex virus is associated with pharyngeal symptoms in college students, and herpes simplex pharyngitis cannot easily be distinguished clinically from other causes of acute pharyngitis in this age group.
 ...
PMID:Pharyngitis associated with herpes simplex virus in college students. 838 78

Mycoplasma pneumoniae causes not only pneumonia but also other respiratory syndromes such as bronchitis, bronchiolitis, pharyngitis, and croup. These infections mimic viral respiratory syndromes. Most cases are treated on an outpatient basis. Epidemics take place at intervals of 4-7 years. The incidence rate is highest among school children and second highest among children < 5 years of age. Among persons who have had M. pneumoniae pneumonia, rates of subsequent infection with this organism are low, and immunity appears to increase with age. The carrier state may last for several months. Patients with humoral immunodeficiency often develop severe infections due to M. pneumoniae, with involvement of the joints; in these individuals the carrier state may persist. M. pneumoniae has been isolated from bronchial washings from children with AIDS. These children have recovered from mycoplasmal infection with appropriate antibiotic treatment. Dermatologic, neurological, cardiac, renal, and pulmonary complications occur, although data on their frequency are lacking.
 ...
PMID:Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. 839 36

Chlamydia pneumoniae has recently been recognized to cause various human respiratory tract diseases, including pharyngitis, bronchitis and pneumonia. The most common pathogens of respiratory tract infections such as Streptococcus pneumoniae and Haemophilus influenzae are frequently present in middle ear effusions. Therefore, it is possible that C. pneumoniae play a role in otitis media with effusion (OME). Isolation of C. pneumoniae from middle ear aspirates of OME was performed by the culture method using the HeLa 229 or HL cell line. Identification as C. pneumoniae was based on positive staining for inclusions by a species-specific fluorescein-conjugated monoclonal antibody. C. pneumoniae was recovered from 17.8% (13 of 73) of the patients with acute OME, and 7.1% (3 of 42) of those with chronic OME, Moreover, antibodies to C. pneumoniae were measured by the microimmunofluorescence method in 14 patients who yielded the agent, and all of them had detectable antibodies to C. pneumoniae. Evidence of recent or current infection by the organism was found in nine patients on the basis of either on IgM antibody titer of 1:16 or higher, or a four-fold rise in the titer of IgG antibody. The study findings indicate that C. pneumoniae can cause OME and that the organism is a new candidate as an etiological agent of middle ear diseases.
 ...
PMID:[Association of Chlamydia pneumoniae infection with otitis media with effusion]. 845 7

Under an influenza surveillance initiated in Pune, India, 2 or 3 dispensaries and small hospitals where patients with acute respiratory disease (ARD) sought medical assistance were chosen for regular weekly visits to collect a sufficient number of specimens. A case of ARD included individuals with the following conditions: common cold, pharyngitis, laryngitis, tracheitis, bronchitis, bronchiolitis, pneumonia, or bronchopneumonia. During the period of surveillance of 1978-90, more than 10,000 cases of ARD among various age groups were investigated. The majority of cases were in children and infants. Most of the patients were seen during investigations of 16 outbreaks of influenza. Generally, the cases presented with 2 or 3 symptoms of respiratory disease and 1 or 2 systemic manifestations. Throat and nasal swabs were collected from ARD cases during the acute phase of their illness (1-4 days). Throat/nasal swabs were taken from over 10,000 ARD cases. About 80% of these specimens were cultivated for influenza virus in embryonated chicken eggs (9-11 days' old) and about 39% in Madin-Darby canine kidney cell culture (MDCK) with crystalline trypsin. Several variants of influenza virus types A and B were isolated during the 16 outbreaks including these variant strains: A/USSR/77 (H1N1) in 1978; A/Singapore/6/86 (H1N1) in 1986; and B/Yamagata/16/88-like in 1990. A total of 290 influenza virus isolates comprising several variants of influenza type A (H3N2) and A (H1N1) and type B were isolated. The variant strains of influenza type A (H1N1), type A (H3N2), and type B circulated regularly either every year or in alternate years. 181 of 290 of the influenza isolates were from children aged 10 years. Analysis of the isolates showed that 174 were from the rainy months of July, August, and September, and the maximum number of 93 occurred in July. Of the 16 outbreaks of influenza, 10 occurred in the rainy season, 3 in the hot season, 1 in the cool season, and 2 in February and March.
 ...
PMID:Influenza surveillance in Pune, India, 1978-90. 849 Sep 80

Patterns of health-care utilization and of morbidity were investigated in a demographically defined community: the 1400 inhabitants of a rural village near Lahore, Pakistan. The data collected, by semi-monthly clinic surveys from February 1982 to January 1983, showed that 42% of the study population sought health care during the year-long study period, between one and 10 (mean 2.1) times each. Females attended the clinics twice as often as males. The 1193 person-visits that were recorded at the field clinics yielded a total of 1354 cases of various diseases. The cumulative number of clinic-visits per person fitted a negative binomial distribution, indicating that health problems were concentrated in a small portion of the population. When the patients were classified according to the International Classification of Diseases, the most common disease category was that of the respiratory system (27.6%), followed by infectious and parasitic diseases (18.7%), diseases of the skin (13.7%) and those of the nervous system and sense organs (10.9%). Classification of the cases by single disease condition indicated that diarrhoea, helminthiasis, malaria, anaemia, conjunctivitis, bronchitis, coryza, pharyngitis, tonsillitis, dyspepsia and pyoderma were the most common diseases. In view of the fact that infectious diseases continue to be a major public health problem in rural Pakistan, the need for a sound health policy that is primarily focused on preventive medicine, especially health education, is apparent.
 ...
PMID:Patterns of health-care utilization and morbidity in a rural community near Lahore, Pakistan. 872 31

To obtain accurate data on the incidence and clinical profile of acute respiratory infections (ARI) in Egyptian infants and children aged 4 years and under, 115 randomly selected health centers in five of the country's 26 governorates participated in an ARI Case Registration System. Each month during 1993, specially trained physicians assigned to the project submitted a case diagnosis form. The survey yielded a total of 75,789 records representing seven categories: very severe disease (0.9%); severe pneumonia (2.9%); pneumonia (9.9%); otitis media (10.7%); pharyngitis (22.8%); asthma (4.8%); and cough, cold, and bronchitis (48.1%). 4.1% of patients were under 2 months old, 29.9% were 2-11 months of age, and 66.0% were 1-4 years old. Pneumonia cases peaked in January and fell off in June. When the reliability of disease symptoms as reported by caretakers was compared to the corresponding clinical signs observed by physicians, specificity was in the 95-97% range, but sensitivity was extremely low (e.g., 48-59% for rapid breathing). This analysis enabled health centers to calculate the annual drug requirements for use in ARI. For example, the finding that 34% of ARI cases involve children under 12 months of age led to a decision to ensure that one-third of the amoxycillin ordered for use in the clinics is of the 125 mg strength.
 ...
PMID:Acute respiratory infections: sentinel survey in Egypt. 875 46

Azithromycin (AZM) was studied for its clinical efficacy in pediatric infections. The study on AZM was carried out in 43 patients whose diagnoses were given as follows: pharyngitis in five cases, tonsillitis in one, bronchitis in four, pneumonia in four, Mycoplasma pneumonia in 14, scarlet fever in nine, impetigo in four, pyodermia in one and Campylobacter enteritis in one. The patients received AZM once daily at 1.6 approximately 20.0 mg/kg body weight for three to five days. Effectiveness of AZM was evaluated in 39 cases and the drug was rated "excellent" in 15, "good" in 19, "fair" in one, "poor" in four, resulting in an efficacy rate of 87.2%. Twenty bacterial isolates were identified as causative isolates in 19 patients: Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, Campylobacter jejuni and Mycoplasma pneumoniae. AZM eradicated 16 isolates but four persisted after therapy. One patient complained of loose stool, while two patients were found with decreases in white blood cell counts, and seven showed increases in eosinophils. However, no serious case of adverse event was reported.
 ...
PMID:[Clinical evaluation of azithromycin in pediatric infections]. 898 54

Azithromycin (AZM), a newly developed azalide antibiotic, was administered at a standard dose of 10 mg/kg once daily for 3 days to pediatric patients with bacterial infections and the therapeutic efficacy of AZM was investigated. 1. A total of 12 patients with the following diseases was evaluated: pharyngitis in two, tonsillitis in four, bronchitis in one, Mycoplasma pneumonia in one, scarlet fever in two and enteritis in two. The drug was rated "excellent" in eight cases and "good" in four. 2. Eleven strains were isolated from patients: five strains of Streptococcus pyogenes, four strains of Haemophilus influenzae, and two strains of Haemophilus parainfluenzae. Isolated bacteria were eradicated in eight strains and persisting in one, resulting in 88.9% in eradication rate. No follow-up examinations in post-treatment were performed in two cases. 3. No adverse reaction was reported, while one case of eosinophilia was noted as an abnormal laboratory test value. 4. As far as compliance is concerned, patients claimed that the formulation of the drug is "easy to take" or "ordinary". With the results presented as above, we have concluded that AZM is a useful antibiotic in pediatric patients with bacterial infections.
 ...
PMID:[Therapeutic efficacy of azithromycin in pediatrics]. 898 55

Azithromycin (AZM) was orally administered to 12 pediatric patients with the following bacterial infections: pharyngitis in four cases, tonsillitis in one, pharyngo-bronchitis in two, and mycoplasmal pneumonia in five. In eleven of the twelve cases (91.7%) was the drug found effective. Neither abnormal clinical findings nor abnormal laboratory test results changes were observed. Eleven of the twelve pediatric patients claimed that the formulation of the drug is easy to take. The above results suggest that AZM is a useful antibiotic drug in the treatment of pediatric patients with bacterial infections.
 ...
PMID:[Therapy with azithromycin in pediatric infections]. 898 56

Fine granules or capsules of azithromycin (AZM) were given to 32 pediatric patients for the treatment of the following diseases: pharyngitis in three cases; tonsillitis in one; bronchitis in six; pneumonia in six; mycoplasmal pneumonia in 14; pertussis and enteritis in one, each. Effectiveness of AZM was evaluated in 30 cases and the drug was rated "excellent" in 18 patients, "good" in 11 and "fair" in one, resulting in a total efficacy rate of 96.7%. Three strains of bacteria were isolated from 3 patients as the causative organisms including: Streptococcus pneumoniae, Haemophilus influenzae and Haemophilus parainfluenzae, from three different patients, respectively. One patient complained of mild diarrhea, another patient mild urticaria. Abnormal laboratory test results were reported as follows: one patient showed a slight decrease in leukocyte count, three patients showed slight increases in eosinophils, and one patient had slight elevations in GOT and GPT. The above results suggest that AZM is a useful antibiotic drug in the treatment of pediatric patients with various bacterial infections.
 ...
PMID:[Clinical studies on azithromycin in pediatrics]. 898 57


<< Previous 1 2 3 4 5 6 7 8 9 10